13F Data
13F filer · CIK 1843547

Vantage Consulting Group Inc

VIRGINIA BEACH, VA · filing since Q4 2020 · last filing Feb 11, 2026
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023
Reported value
$19.7M
+$8.5M vs prior
Positions
3
New / sold out
0 / 0
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $0
Top-10 weight
100.0%

Biggest buys vs Q3 2025

No new or increased positions this quarter.

Biggest sells vs Q3 2025

No reduced or sold positions this quarter.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2020: $1.2BQ1 2021: $498.2MQ2 2021: $574.8MQ3 2021: $467.0MQ4 2021: $372.0MQ1 2022: $256.3MQ2 2022: $178.3MQ3 2022: $171.2MQ4 2022: $169.4MQ1 2023: $176.1MQ2 2023: $173.9MQ3 2023: $149.2MQ4 2023: $148.8MQ1 2024: $157.3MQ2 2024: $134.6MQ3 2024: $11.4MQ4 2024: $10.5MQ1 2025: $5.0MQ2 2025: $5.7MQ3 2025: $11.2MQ4 2025: $19.7M
Q4 2020Q4 2025

Holdings · Q4 2025

#SecuritySharesValueWeight
1Babcock & Wilcox Enterprises Inc.COM2,416,200$15.3M77.68%
2ADC Therapeutics SACOM682,998$2.4M12.23%
3Cibus, Inc.COM1,143,949$2.0M10.09%